This page lists all known medications that could potentially lead to 'Muscular ventricular septal defect' as a side effect. It's important to note that mild side effects are quite common with ...

Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...

After bicuspid aortic valve, ventricular septal defects (VSDs) are the most common congenital heart abnormalities. Of all congenital defects, around 20% are solitary lesions and another 10% are ...

Ventricular septal defect is an abnormal hole in the septum that separates the two bottom chambers of the heart called ventricles. Like Atrial septal defect (ASD), there are no evident reasons to say ...

Percutaneous closure of symptomatic ventricular septal defects in children can be achieved with off-label use of an occluder device. A research letter published online November 7, 2012, ahead of print ...

Schaffhausen, Switzerland. Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained European CE Mark approval for its dedicated muscular ...

The National Institute for Health and Clinical Excellence is examining endovascular closure of perimembranous ventricular septal defect and will publish guidance on its safety and efficacy to the NHS ...

The interventricular septum separates the heart’s two ventricles and plays a vital role in maintaining correct bloodflow. Sometimes a defect can occur or be present from birth. This can increase the ...

Ventricular septal defect (VSD) is the persistence of one or more holes in the septum that separates the left and right ventricles of the heart. VSD is the most common congenital heart defect. Left ...